Literature DB >> 8622722

Dermatomal/segmental somatosensory evoked potential evaluation of L5/S1 unilateral/unilevel radiculopathies.

D Dumitru1, P Dreyfuss.   

Abstract

Dermatomal and segmental somatosensory evoked potentials (SEPs) have been reported to be of diagnostic utility in unilateral/unilevel L5 and S1 radiculopathies. This investigation employs history, physical examination, imaging studies, and electrodiagnostic medicine evaluations to clearly define unilateral/unilevel L5 or S1 nerve root compromise. Inclusion criteria require all of the preceding diagnostic methods to corroborate a specific nerve root lesion. Regression equation analysis for cortical P1 latencies evaluating age and height based on comparable patient and control reference populations reveals segmental and dermatomal sensitivities for L5 radiculopathies to be 70% and 50%, respectively, at 90% confidence intervals. Similar sensitivities are obtained for 2 standard deviation mean cortical P1 latencies. Side-to-side cortical P1 latency difference data reveal segmental and dermatomal sensitivities for S1 radiculopathies to be 50% and 10%, respectively, at two standard deviations. The clinical utility of both segmental and dermatomal SEPs are questionable in patients with known unilateral/unilevel L5 and S1 nerve root compromise.

Entities:  

Mesh:

Year:  1996        PMID: 8622722     DOI: 10.1002/(SICI)1097-4598(199604)19:4<442::AID-MUS3>3.0.CO;2-C

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  Diagnostic use of dermatomal somatosensory-evoked potentials in spinal disorders: Case series.

Authors:  Pinar Yalinay Dikmen; A Emre Oge
Journal:  J Spinal Cord Med       Date:  2013-05-08       Impact factor: 1.985

2.  A Comparison of Interside Asymmetries of Lower Extremity Somatosensory Evoked Potentials in Anesthetized Patients with Unilateral Lumbosacral Radiculopathy.

Authors:  Qing Yue; Tyson Hale; Aaron Knecht
Journal:  Asian Spine J       Date:  2017-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.